This study tests whether adding the experimental drug ivaltinostat to standard chemotherapy (capecitabine) can help control metastatic pancreatic cancer longer than chemo alone. It is for people whose cancer has not worsened after initial treatment with FOLFIRINOX. The trial has …
Phase: PHASE1, PHASE2 • Sponsor: CG Pharmaceuticals, Inc • Aim: Disease control
Last updated May 06, 2026 16:01 UTC